Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × IMM-101 × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Dermatologic 1

Conditions

Sarcoma 1 Neoplasm Metastasis 1 Melanoma 1

Interventions

pembrolizumab 11 Gemcitabine 10 Doxorubicin 10 Cyclophosphamide 9 Ibandronic Acid 8 pazopanib 7 Specimen Handling 7 Nivolumab 7 Radiosurgery 6 Imatinib Mesylate 6 Biopsy 6 Bevacizumab 6 Magnetic Resonance Spectroscopy 5 Irinotecan 5 regorafenib 4 Zoledronic Acid 4 Ipilimumab 4 Ifosfamide 4 Fluorouracil 4 Docetaxel 4 Cetuximab 4 sargramostim 3 conatumumab 3 cemiplimab 3 Sunitinib 3 Radiation 3 Paclitaxel 3 Leucovorin 3 Cryosurgery 3 Cisplatin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03009058 2024-11-25

MODULATE

Immodulon Therapeutics Ltd

Phase 1/2 Terminated

2 enrolled 7 charts

DermatologicSarcoma

Melanoma, Neoplasm Metastasis, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡